A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against Dengue Virus

NCT04935801 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Dengue

Interventions

BIOLOGICAL: LD vehicle-GNP
BIOLOGICAL: LD PepGNP-Dengue
BIOLOGICAL: HD vehicle-GNP
BIOLOGICAL: HD PepGNP-Dengue

Sponsor

Gylden Pharma Ltd

Collaborators

[object Object]
[object Object]